Dopamine and Serotonin Receptor Heterodimers as Novel, Multi-Target Pharmacological Targets for Personalized Medicine

The dopaminergic (DA) and serotonergic (5-HT) neurotransmitter systems play essential roles in mood regulation, cognition, motor function, learning, sleep, and reward mechanisms. Historically, dopamine and serotonin receptors were viewed as independent molecular entities regulating separate pathways. However, modern molecular pharmacology has revealed that these receptors frequently interact to form heterodimers, producing new functional signaling units with unique pharmacological identities ^[1].

These heterodimers challenge the classical Lock-and-Key model of drug action and instead support a multi-target and network-based therapeutic approach, which is essential in disorders like schizophrenia, depression, anxiety, addiction, and Parkinson’s disease—conditions characterized by imbalance across multiple neurotransmitter systems ^[2].

Emerging evidence suggests that receptor heterodimers exhibit:

• altered ligand affinity
• modified G-protein coupling
• biased signaling
• altered desensitization and internalization
• unique structural conformations
• inter-receptor allosteric modulation

Such features make dopamine–serotonin heterodimers promising targets for precision medicine, especially as genetic and epigenetic variations are known to modulate their expression and function ^[3].

2. BIOLOGY AND STRUCTURE OF GPCR HETERODIMERS

2.1 General Mechanism of GPCR Dimerization

GPCRs were traditionally believed to function as monomers; however, several biochemical and imaging studies demonstrate that they can exist as monomers, homodimers, or heterodimers. Dopamine and serotonin receptors dimerize through:

• transmembrane helices (especially TM4, TM5, TM6)
• intracellular loops (IL2, IL3)
• extracellular domains

This dimerization allows allosteric communication, where ligand binding to one receptor alters the conformation of the partner receptor, affecting its activity ^[4].

2.2 Structural Dynamics and Conformational Changes

Cryo-EM and FRET-based studies reveal that heterodimerization causes the receptors to adopt unique conformational states, distinct from their monomeric forms ^[5]. These structural changes are responsible for biased agonism and selective pathway activation.

2.3 Signal Transduction and Pathway Bias

Depending on receptor pairing, heterodimers may shift signaling from:

• Gαi → Gαq
• Gαq → Gαs
• G-protein pathways → β-arrestin pathways

This shift forms the molecular basis for reduced side effects and improved clinical outcomes in drugs targeting heterodimers ^[6].

3. MAJOR DOPAMINE–SEROTONIN RECEPTOR HETERODIMERS

3.1 D2–5-HT2A Heterodimer

This is the most clinically important heterodimer, highly implicated in schizophrenia and psychosis. Allosteric interactions here explain why atypical antipsychotics simultaneously target D2 and 5-HT2A receptors ^[7].

• 5-HT2A activation enhances D2 internalization.
• D2 agonists reduce 5-HT2A-mediated calcium signaling.

This cross-talk forms the pharmacological foundation for atypical antipsychotics such as clozapine and risperidone ^[8].

3.2 D1–5-HT2A Heterodimer

D1–5-HT2A interactions regulate:

• working memory
• cortical glutamate release
• hallucinogenic responses
• LSD, psilocin, and mescaline exert effects partly through this heterodimer ^[9].

3.3 D2–5-HT1A Heterodimer

This heterodimer plays a critical role in:

• depression
• anxiety
• stress adaptability
• Co-modulation of D2 and 5-HT1A signaling forms the rational basis for multi-target antidepressant development ^[10].

3.4 D4–5-HT2A Heterodimer

This pair influences:

• ADHD
• impulsivity
• novelty-seeking behaviors
• Polymorphisms in DRD4 (especially the 7-repeat allele) alter heterodimer behavior and are linked to behavioural variability ^[11].

4. MECHANISMS OF DOPAMINE RECEPTOR SIGNALLING

The prevailing convention was that dopamine receptors were considered to signal exclusively through G protein-dependent cellular processes. The D₁-class receptors (D₁ and D₅ receptors) are primarily coupled to Gα_s/olf proteins and stimulate the activity of AC and the production of the second messenger cAMP (Figure 1). In contrast, the D₂ class receptors (D_2S, D_2L, D₃ and D₄ receptors) are associated with Gα_i/o proteins to inhibit the production of cAMP  (Figure 2).^[22].

Figure 1:Schematic diagram representing the signalling cascades activated by the D₁ dopamine receptor (D1R). D5R, D₅ dopamine receptor; D1R:D2R, D₁–D₂ receptor heteromer.

Figure 2:Schematic diagram representing the signalling cascades activated by the D₂ dopamine receptor (D2R). BMAL1, aryl hydrocarbon receptor nuclear translocator-like protein; Clock, circadian locomotor output cycles kaput gene; Cry2, cryptochrome 2; KLC2, kinesin light chain 2; Rev/Erbα, nuclear receptor subfamily 1, group D, member 1

 5.PHARMACOLOGICAL IMPLICATIONS

5.1 Altered Ligand Binding and Receptor Sensitivity

Ligand affinity often changes dramatically when receptors form heterodimers. For example, the D2–5-HT2A dimer displays reduced sensitivity to selective D2 agonists due to allosteric constraints ^[12].

5.2 Biased Signaling and Allosteric Modulation

Heterodimers may favor β-arrestin pathways over G-protein pathways, supporting development of drugs with fewer side effects (e.g., avoiding extrapyramidal symptoms) ^[13].

5.3 Drug Development Approaches

• Bitopic ligands: target orthosteric + allosteric sites
• Bivalent ligands: simultaneous dual-receptor targeting
• Heterodimer-selective agonists

These innovations create high precision in neuropsychiatric therapy ^[14].

6. CLINICAL RELEVANCE IN NEUROPSYCHIATRIC DISORDERS

6.1 Schizophrenia

The D2–5-HT2A heterodimer is central to antipsychotic drug action. Genetic polymorphisms such as DRD2 Taq1A and HTR2A rs6311 influence patient response to atypical antipsychotics ^[15].

6.2 Depression and Mood Disorders

The D2–5-HT1A heterodimer explains why combining dopaminergic and serotonergic modulation enhances antidepressant response, especially in treatment-resistant depression ^[16].

6.3 Parkinson’s Disease

Interactions between dopaminergic loss and serotonergic compensation lead to dyskinesia. Targeting heterodimers may reduce L-DOPA-induced dyskinesia ^[17].

6.4 Addiction and Substance Use Disorders

Altered D1–5-HT2A signaling modifies reward circuitry, influencing vulnerability to nicotine, cocaine, and alcohol dependence ^[18].

7. PERSONALIZED MEDICINE PERSPECTIVE

Personalized medicine is also termed as individualized medicine.

PRINCIPLE: Right Drug to the Right Patient for Right Disease at Right Time with the Right Dose.

It enables pharmaceutical company to develop more effective medicine with less side effects.

For personalized medicine the physician access the genetic profile of the patient which allow them to use existing medicine more effectively and safely, with this individual will be able to better manage their health based on understanding their genetic profile^[23].

BIOELECTRONIC MEDICINES

Benefits of personalized medicine are:

• Better drug delivery to patient instead of trial and error.
• Customized pharmaceutical may eliminate the life threatening adverse reactions.
• Reduced cost of clinical trials by quickly identifying their failures
• Improved efficiency of drug

Following Study involved in development of personalized medicine.

• The Human Genome
• Chromosome
• The Genetic Code
• Gene Expression

ODNA Sequence and Structure

The process of personalization starts at the Developmental stage of medicine and based on pharmacogenomics and pharmacogenetic.

• Pharmacogenomics is the study of variation on DNA and RNA characteristics related to drug response.
• Pharmacogenetics is the study of linkage between individual genotype and individual ability to metabolize a foreign compound.

Role Of Pharmacogenetics in Pharmaceutical Industry

• Study of Drug Metabolism and Pharmacological effect.
• Predicting Genetically Determined Adverse Reaction.
• Drug Discovery and Development and as an aid to planning Clinical trials.

Customized Drug Delivery System

• 3D Printing.
• Telepharmacy
• Bioelectronics Devices

3D printing:- the process of making three-Dimensional solid object from a Digital file by layer-to-layer fabrication.

Advantages of 3D Printing:-

• High production rate due to fast Operating system.
• Reduction of material wastage which can save the cost of production.
• Ability to achieve accuracy especially for potent drug.

Types of 3D Printing Technology

1. Inkjet printing
2. Fused Deposition modelling
3. Direct write
4. Extrusion

Inkjet Printing: different combination of active ingridients and excipients are precisely sprayed in small droplets which then solidifies into solid dosage form

Direct Write: It is a computer aided program that moves in a pattern to achieve layer by layer 3D micro transformation.

Fused Deposition Modelling: multiple dosage form is produced by applying polymer as apart of framework in this process polymer is melted and pass through a movable heated nozzle.

Extrusion: Extrusion is the most widely used 3D printing technology. In an extrusion process, material is extruded from robotically-actuated nozzles.

Example of 3D Printed drugs:

TELEPHARMACY

Deliver pharmaceutical care via telecommunication to patient in location where they may not have direct contact with a pharmacist. Telepharmacy service includes Drug monitoring therapy, patient counseling, authorize for prescription drug. Also used for videoconferencing in pharmacy for providing education, training to pharmacy staff.

Disadvantage are decreased human interaction between medical professional and patients. An increased Risk of error when medical services deliver in the absence of registered professional^[24].

Types of Telepharmacy:

1. Inpatient
2. Remote dispensing
3. Remote counseling

Inpatient:- Pharmacist refers to a remote area where they receive medication order before hospital staff administers the drug to patient, real time medication review and verification is done by pharmacist.

Remote Dispensing:- Pharmacist supervise technician, review prescription and perform their duty from a remote location via technology.

Remote Counseling:- Pharmacist provide counseling to the patient via live and interactive video session^[25].

How Does Personalized Medicine Help Patients?

Personalized medicine can involve preventive, diagnostic, or treatment strategies.

Prevention

Preventive personalized medicine is designed to help patients understand their molecular and environmental disease risks.

Diagnosis

Diagnostic tests can uncover the root molecular causes of certain diseases. The results may point to a promising targeted treatment option that would otherwise be overlooked^32].

Treatment

Personalized medicines can address the root molecular causes of certain diseases. For many patients, molecularly targeted treatment regimens are safer and more effective than one-size-fits-all options^[18].

Application of Personalized Medicine

1. Diagnosing  disease  earlier  in  development using  optimal  surveillance,  thereby  allowing more  effective  interventions  or  treatment options.
2. Avoiding  preventable  drug  related complications  and  side effects  resulting from generic “one size fits all” drug prescribing.
3. By ensuring appropriate drug is used and that the  dosing  regimen  takes  into  consideration any  genetic  variants enhance  the therapeutic efficacy  which  may  affect metabolism  of  the drug.
4. If someone is at increased risk of developing a disease, followed by promotion of and support for compliance with available prevention strategies.

Advantages of Personalized Medicine

1. Decreased health care cost.
2. Due  to better  targeted  therapies,  there will  be higher probability to get desired outcomes.
3. Mainly  focus  on  prevention  and  prediction  of diseases rather than reaction.
4. Probability  of  negative  side  effects  can  be reduced.
5. Disease intervention will be earlier in comparison to the past^[9].

Table 2. Specific examples of personalized medicine or personalized health care.